Bundle in the Bronx: Impact of a Transition-of-Care Outpatient Parenteral Antibiotic Therapy Bundle on All-Cause 30-Day Hospital Readmissions
- PMID: 28852672
- PMCID: PMC5570156
- DOI: 10.1093/ofid/ofx097
Bundle in the Bronx: Impact of a Transition-of-Care Outpatient Parenteral Antibiotic Therapy Bundle on All-Cause 30-Day Hospital Readmissions
Abstract
Background: A streamlined transition from inpatient to outpatient care can decrease 30-day readmissions. Outpatient parenteral antibiotic therapy (OPAT) programs have not reduced readmissions; an OPAT bundle has been suggested to improve outcomes. We implemented a transition-of-care (TOC) OPAT bundle and assessed the effects on all-cause, 30-day hospital readmission.
Methods: Retrospectively, patients receiving postdischarge intravenous antibiotics were evaluated before and after implementation of a TOC-OPAT program in Bronx, New York, between July, 2015 and February, 2016. Pearson's χ2 test was used to compare 30-day readmissions between groups, and logistic regression was used to adjust for covariates. Time from discharge to readmission was analyzed to assess readmission risk, using log-rank test to compare survival curves and Cox proportional hazards model to adjust for covariates. Secondary outcomes, 30-day emergency department (ED) visits, and mortality were analyzed similarly.
Results: Compared with previous standard care (n = 184), the TOC-OPAT group (n = 146) had significantly lower 30-day readmissions before (13.0% vs 26.1%, P < .01) and after adjustment for covariates (odds ratio [OR] = 0.51; 95% confidence interval [CI], 0.27-0.94; P = .03). In time-dependent analyses, TOC-OPAT patients were at significantly lower risk for readmission (log-rank test, P < .01; hazard ratio = 0.56; 95% CI, 0.32-0.97; P = .04). Propensity-matched sensitivity analysis showed lower readmissions in the TOC-OPAT group (13.6% vs 24.6%, P = .04), which was attenuated after adjustment (OR = 0.51; 95% CI, 0.25-1.05; P = .07). Mortality and ED visits were similar in both groups.
Conclusions: Our TOC-OPAT patients had reduced 30-day readmissions compared with the previous standard of care. An effective TOC-OPAT bundle can successfully improve patient outcomes in an economically disadvantaged area.
Keywords: bundle; outpatient parenteral antibiotic therapy; readmission; transitional care model..
Figures

Similar articles
-
Impact of a nurse practitioner-led dedicated outpatient parenteral antibiotic therapy clinic on patient outcomes and administrative workload: a retrospective cohort study.Ther Adv Infect Dis. 2024 Dec 23;11:20499361241305308. doi: 10.1177/20499361241305308. eCollection 2024 Jan-Dec. Ther Adv Infect Dis. 2024. PMID: 39717489 Free PMC article.
-
The Impact of an Infectious Diseases Transition Service on the Care of Outpatients on Parenteral Antimicrobial Therapy.J Pharm Technol. 2013 Oct;29(5):205-214. doi: 10.1177/8755122513500922. J Pharm Technol. 2013. PMID: 25621307 Free PMC article.
-
Electronic health record-based readmission risk model performance for patients undergoing outpatient parenteral antibiotic therapy (OPAT).PLOS Digit Health. 2023 Aug 2;2(8):e0000323. doi: 10.1371/journal.pdig.0000323. eCollection 2023 Aug. PLOS Digit Health. 2023. PMID: 37531342 Free PMC article.
-
A Bundle of the "Top 10" Outpatient Parenteral Antimicrobial Therapy Publications in 2023.Open Forum Infect Dis. 2024 Oct 29;11(11):ofae635. doi: 10.1093/ofid/ofae635. eCollection 2024 Nov. Open Forum Infect Dis. 2024. PMID: 39507884 Free PMC article. Review.
-
Outpatient Parenteral Antimicrobial Therapy Among People Who Inject Drugs: A Review of the Literature.Open Forum Infect Dis. 2018 Aug 7;5(9):ofy194. doi: 10.1093/ofid/ofy194. eCollection 2018 Sep. Open Forum Infect Dis. 2018. PMID: 30211247 Free PMC article. Review.
Cited by
-
Factors associated with loss to follow-up in outpatient parenteral antimicrobial therapy: A retrospective cohort study.Infect Control Hosp Epidemiol. 2024 Mar;45(3):387-389. doi: 10.1017/ice.2023.216. Epub 2023 Oct 2. Infect Control Hosp Epidemiol. 2024. PMID: 37782035 Free PMC article.
-
Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant Pseudomonas aeruginosa Infection in the Outpatient Setting.Antibiotics (Basel). 2023 Jul 21;12(7):1214. doi: 10.3390/antibiotics12071214. Antibiotics (Basel). 2023. PMID: 37508309 Free PMC article.
-
Implementing a Toolkit to Improve the Education of Patients on Home-Based Outpatient Parenteral Antimicrobial Therapy (OPAT).Jt Comm J Qual Patient Saf. 2022 Sep;48(9):468-474. doi: 10.1016/j.jcjq.2022.05.008. Epub 2022 May 31. Jt Comm J Qual Patient Saf. 2022. PMID: 35850954 Free PMC article.
-
Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK.JAC Antimicrob Resist. 2019 Aug 26;1(2):dlz026. doi: 10.1093/jacamr/dlz026. eCollection 2019 Sep. JAC Antimicrob Resist. 2019. PMID: 34222901 Free PMC article. Review.
-
Current Practices and Opportunities for Outpatient Parenteral Antimicrobial Therapy in Hospitals: A National Cross-Sectional Survey.Antibiotics (Basel). 2022 Oct 1;11(10):1343. doi: 10.3390/antibiotics11101343. Antibiotics (Basel). 2022. PMID: 36290001 Free PMC article.
References
-
- Balinsky W, Nesbitt S. Cost-effectiveness of outpatient parenteral antibiotics: a review of the literature. Am J Med 1989; 87:301–5. - PubMed
-
- Grayson ML, Silvers J, Turnidge J. Home intravenous antibiotic therapy. A safe and effective alternative to inpatient care. Med J Aust 1995; 162:249–53. - PubMed
-
- Dalovisio JR, Juneau J, Baumgarten K, Kateiva J. Financial impact of a home intravenous antibiotic program on a medicare managed care program. Clin Infect Dis 2000; 30:639–42. - PubMed
-
- Ruh CA, Parameswaran GI, Wojciechowski AL, Mergenhagen KA. Outcomes and pharmacoeconomic analysis of a home intravenous antibiotic infusion program in veterans. Clin Ther 2015; 37:2527–35. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources